Double autophagy modulators reduce 2-deoxyglucose uptake in sarcoma patients
Oncotarget2015Vol. 6(30), pp. 29808–29817
Citations Over TimeTop 15% of 2015 papers
Mau‐Shin Chi, Cheng-Yen Lee, Su-Chen Huang, Kai-Lin Yang, Hui-Ling Ko, Yen-Kung Chen, Chen-Han Chung, Kuang‐Wen Liao, Kwan-Hwa Chi
Abstract
The results of reduced SUVmax without tumor volume reduction after two weeks of Rapa and HCQ treatment may indicate that non-proliferative glycolysis occurred mainly in the cancer associated fibroblast compartment, and decreased glycolytic activity was evident from Rapa + HCQ double autophagy modulator treatment.
Related Papers
- → The effects of hydroxychloroquine on endothelial dysfunction(2016)47 cited
- → Similar incidence of coronavirus disease 2019 (COVID-19) in patients with rheumatic diseases with and without hydroxychloroquine therapy(2021)8 cited
- → Similar incidence of Coronavirus Disease 2019 (COVID-19) in patients with rheumatic diseases with and without hydroxychloroquine therapy(2020)5 cited
- → The effect of hydroxychloroquine against SARS-CoV-2 infection in rheumatoid arthritis patients(2020)
- Autophagy in cancer biology and therapy(2014)